Background: Dysnatremia, which is associated with increased mortality in general intensive care units (ICU), has not been thoroughly studied in neurologic ICU (NICU). Methods: Prevalence of dysnatremia was retrospectively assessed. The multivariable binary logistic regression model was used to determine the influence of dysnatremia on mortality. Results: Of 519 patients, 106 (20.4%) were admitted with hyponatremia and 177 (34.10%) with hypernatremia. Hypernatremia was detected in 69 (13.29%) patients on admission to NICU and in 108 patients (20.81%) during the ICU stay. However, the incidence of dysnatremia did not differ across the neurological categories (p = 0.4690). ICU stay in patients with acquired hypernatremia (22.3 w 25.35 days) was longer than those with admission hypernatremia (13.5 w 12.8 days) or with consistent normonatremia (16.16 w 20.06 days). The other indicators such as Acute Physiology and Chronic Health Evaluation II, Glasgow Coma Scale score, urinary catheterization, and incidence of pneumonia were also associated with the serum sodium concentrations. Hypernatremia both on admission and acquired in NICU could significantly differentiate between survivors and nonsurvivors (p = 0.002 and <0.0001). However, only NICU-acquired hypernatremia was the independent risk factor for mortality with high sensitivity (p = 0.000). Conclusions: Dysnatremia is more common in NICU, whereas only acquired-hypernatremia was independently associated with outcome. i 2014 S. Karger AG, Basel

Aiyagari V, Deibert E, Diringer MN: Hypernatremia in the neurologic intensive care unit: how high is too high? J Crit Care 2006;21:163-172.
Tisdall M, Crocker M, Watkiss J, Smith M: Disturbances of sodium in critically ill adult neurologic patients: a clinical review. J Neurosurg Anesthesiol 2006;18:57-63.
Fisher LA, Ko N, Miss J, Tung PP, Kopelnik A, Banki NM, Gardner D, Smith WS, Lawton MT, Zaroff JG: Hypernatremia predicts adverse cardiovascular and neurological outcomes after SAH. Neurocrit Care 2006;5:180-185.
Diringer MN, Zazulia AR: Hyponatremia in neurologic patients: consequences and approaches to treatment. Neurologist 2006;12:117-126.
Rabinstein AA, Wijdicks EF: Hyponatremia in critically ill neurological patients. Neurologist 2003;9:290-300.
Fraser JF, Stieg PE: Hyponatremia in the neurosurgical patient: epidemiology, pathophysiology, diagnosis, and management. Neurosurgery 2006;59:222-229; discussion 222-229.
Arampatzis S, Frauchiger B, Fiedler GM, Leichtle AB, Buhl D, Schwarz C, Funk GC, Zimmermann H, Exadaktylos AK, Lindner G: Characteristics, symptoms, and outcome of severe dysnatremias present on hospital admission. Am J Med 2012;125:1125.e1121-e1125, e1127.
Alharfi IM, Stewart TC, Kelly SH, Morrison GC, Fraser DD: Hypernatremia is associated with increased risk of mortality in pediatric severe traumatic brain injury. J Neurotrauma 2013;30:361-366.
Adrogue HJ, Madias NE: Hypernatremia. N Engl J Med 2000;342:1493-1499.
Lindner G, Schwarz C, Grussing H, Kneidinger N, Fazekas A, Funk GC: Rising serum sodium levels are associated with a concurrent development of metabolic alkalosis in critically ill patients. Intensive Care Med 2013;39:399-405.
Spatenkova V, Bradac O, Skrabalek P: Outcome and frequency of sodium disturbances in neurocritically ill patients. Acta Neurol Belg 2013;113:139-145.
Sakr Y, Rother S, Ferreira AM, Ewald C, Dunisch P, Riedemmann N, Reinhart K: Fluctuations in serum sodium level are associated with an increased risk of death in surgical ICU patients. Crit Care Med 2013;41:133-142.
Funk GC, Lindner G, Druml W, Metnitz B, Schwarz C, Bauer P, Metnitz PG: Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med 2010;36:304-311.
Wells DL, Swanson JM, Wood GC, Magnotti LJ, Boucher BA, Croce MA, Harrison CG, Muhlbauer MS, Fabian TC: The relationship between serum sodium and intracranial pressure when using hypertonic saline to target mild hypernatremia in patients with head trauma. Crit Care 2012;16:R193.
Maggiore U, Picetti E, Antonucci E, Parenti E, Regolisti G, Mergoni M, Vezzani A, Cabassi A, Fiaccadori E: The relation between the incidence of hypernatremia and mortality in patients with severe traumatic brain injury. Crit Care 2009;13:R110.
Li M, Hu YH, Chen G: Hypernatremia severity and the risk of death after traumatic brain injury. Injury 2012;44:1213-1218.
Lindner G, Funk GC, Lassnigg A, Mouhieddine M, Ahmad SA, Schwarz C, Hiesmayr M: Intensive care-acquired hypernatremia after major cardiothoracic surgery is associated with increased mortality. Intensive Care Med 2010;36:1718-1723.
Lindner G, Kneidinger N, Holzinger U, Druml W, Schwarz C: Tonicity balance in patients with hypernatremia acquired in the intensive care unit. Am J Kidney Dis 2009;54:674-679.
Stelfox HT, Ahmed SB, Khandwala F, Zygun D, Shahpori R, Laupland K: The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units. Crit Care 2008;12:R162.
Waikar SS, Mount DB, Curhan GC: Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med 2009;122:857-865.
Hoorn EJ, Betjes MG, Weigel J, Zietse R: Hypernatraemia in critically ill patients: too little water and too much salt. Nephrol Dial Transplant 2008;23:1562-1568.
Ryu JH, Walcott BP, Kahle KT, Sheth SA, Peterson RT, Nahed BV, Coumans JV, Simard JM: Induced and sustained hypernatremia for the prevention and treatment of cerebral edema following brain injury. Neurocrit Care 2013;19:222-231.
Hiyama TY, Matsuda S, Fujikawa A, Matsumoto M, Watanabe E, Kajiwara H, Niimura F, Noda M: Autoimmunity to the sodium-level sensor in the brain causes essential hypernatremia. Neuron 2010;66:508-522.
Lindner G, Funk GC, Schwarz C, Kneidinger N, Kaider A, Schneeweiss B, Kramer L, Druml W: Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis 2007;50:952-957.
Ganz T: Antimicrobial polypeptides in host defense of the respiratory tract. J Clin Invest 2002;109:693-697.
Zabner J, Seiler MP, Launspach JL, Karp PH, Kearney WR, Look DC, Smith JJ, Welsh MJ: The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing. Proc Natl Acad Sci U S A 2000;97:11614-11619.
Doss M, White MR, Tecle T, Hartshorn KL: Human defensins and LL-37 in mucosal immunity. J Leukoc Biol 2010;87:79-92.
Putsep K, Carlsson G, Boman HG, Andersson M: Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 2002;360:1144-1149.
Christensen RD, Henry E, Baer VL, Hoang N, Snow GL, Rigby G, Burnett J, Wiedmeier SE, Faix RG, Eggert LD: A low-sodium solution for airway care: results of a multicenter trial. Respir Care 2010;55:1680-1685.
Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA, Muller DN, Hafler DA: Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013;496:518-522.
Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S, Kishi Y, Regev A, Kuchroo VK: Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013;496:513-517.
Gonda DD, Meltzer HS, Crawford JR, Hilfiker ML, Shellington DK, Peterson BM, Levy ML: Complications associated with prolonged hypertonic saline therapy in children with elevated intracranial pressure. Pediatr Crit Care Med 2013;14:610-620.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.